Publications Repository

Publications Repository

Search 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • Search
  • Home
  • ICR Divisions
  • Clinical Studies
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show advanced filtersHide advanced filters

Filters

Use filters to refine the search results.

Now showing items 1-1 of 1

  • Sort Options:
  • Relevance
  • Issue date (newest)
  • Issue date (oldest)
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. 

Rosell, R; Dafni, U; Felip, E; Curioni-Fontecedro, A; Gautschi, O; et al. (2017-05)
Background The tyrosine kinase inhibitor erlotinib improves the outcomes of patients with advanced non-small-cell lung carcinoma (NSCLC) harbouring epidermal growth factor receptor (EGFR) mutations. The coexistence of the ...

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types

Discover

AuthorMarsden, (1)Popat, Sanjay (1)SubjectAged (1)Antineoplastic Combined Chemotherapy Protocols (1)
BELIEF collaborative group (1)
Bevacizumab (1)Carcinoma, Non-Small-Cell Lung (1)... View MoreDate Issued2017 (1)Publication TypeJournal Article (1)
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.